The vaccine’s efficacy rate is 72% in the United States and 57% in South Africa, where a highly contagious variant is driving most cases.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MiktSL
via IFTTT
Johnson & Johnson’s vaccine offers strong protection but fuels concern about variants
The vaccine’s efficacy rate is 72% in the United States and 57% in South Africa, where a highly contagious variant is driving most cases.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MiktSL
via IFTTT
0 comments:
Post a Comment